Evaluating Surgical Outcomes of Robot Assisted Simple Prostatectomy in the Retreatment Setting.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
12 2022
Historique:
received: 08 03 2022
revised: 20 07 2022
accepted: 27 07 2022
pubmed: 22 8 2022
medline: 7 12 2022
entrez: 21 8 2022
Statut: ppublish

Résumé

To report perioperative and postoperative outcomes in men who undergo salvage RASP (sRASP) following some other endoscopic outlet procedure for benign prostate enlargement (BPE) compared to those undergoing RASP for primary treatment (pRASP). A prospectively maintained database consisting of all RASP surgeries (December 2014-October 2019) performed at our institution by 3 different urologists was used. Patients who had received an endoscopic procedure for BPE prior to their RASP (sRASP) were compared to those who had not had a prior outlet procedure (pRASP). In total, 310 men underwent RASP during the study period. Of those, 30 (9.7%) had undergone an endoscopic procedure prior to surgery. There were no significant differences in age, race, ASA, BMI, prostate volume, PSA or rates of preoperative retention (P> .05 for all). Men who were treatment-naive had significantly higher preoperative International Prostate Symptom Scores (IPSS) than men who had a prior procedure (18.3 ± 7.7 vs 13.6 ± 6.2, P = .008). However, there were no significant differences in functional or quality of life outcomes between the 2 groups (P > .05 for all). There were no significant differences in perioperative or post-operative outcomes between the 2 groups. Furthermore, rates of post-operative complications and incontinence were similar between groups (11% vs 10%, P = .9 and 2% vs 0%, P = 1 respectively). Performing a RASP after prior endoscopic procedure for BPE was found to be safe and effective. Success and complication rates were similar to patients with no prior procedures.

Identifiants

pubmed: 35988733
pii: S0090-4295(22)00655-0
doi: 10.1016/j.urology.2022.07.044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-116

Informations de copyright

Published by Elsevier Inc.

Auteurs

Alaina Garbens (A)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Hal D Kominsky (HD)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Jessica Dai (J)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Ryan L Steinberg (RL)

Department of Urology, University of Iowa, Iowa City, IA.

Hersh Trivedi (H)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Sam Kusin (S)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Claus Roehrborn (C)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Jeffrey C Gahan (JC)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: jeffrey.gahan@utsouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH